company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6674000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6674000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6674000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1701000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6123000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7824000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1150000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,558000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,235000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-321000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1471000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1471000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1471000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1471000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1490799.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1490799.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 17:04:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16897000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1863000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7408000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9271000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7626000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,491000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-78000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-564000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7062000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7062000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7062000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7062000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1492021.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.73
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14436582.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:00:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2209000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2209000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2209000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2626000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12689000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15315000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13106000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,642000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13697000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27999895.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27999895.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:39:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2857000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2857000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2857000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2353000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15473000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17826000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14969000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,351000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-326000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15295000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28067181.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28067181.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q2,2011-04-01,2011-06-30,2011-08-12 17:04:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12644000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12644000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12644000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2703000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14013000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16716000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4072000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,351000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4392000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4072000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28174576.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28174576.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28174576.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 16:21:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2596000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2596000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2596000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2870000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13922000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16792000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,365000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4413000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4756000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18952000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28109302.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28109302.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2417000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2417000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2417000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3430000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12668000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16098000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13681000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,654000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-633000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14314000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14314000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14327000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14327000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29907348.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29907348.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:39:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2562000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2562000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2562000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2671000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14100000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16771000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14209000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,638000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-631000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14840000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31600000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31600000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31504723.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:52:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2473000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2473000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2473000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2751000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13551000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16302000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13829000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,616000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-615000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14444000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31400000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31400000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31551714.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 16:40:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3288000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3288000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3288000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2762000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11999000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14761000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11473000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1006000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1016000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12489000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12489000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12476000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12476000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31901966.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31901966.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31900000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1708000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1708000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1708000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4716000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11159000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15875000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14167000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,911000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15064000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14167000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35846287.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:00:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3424000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3424000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3424000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5086000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10146000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15232000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11808000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2284000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2288000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14096000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39273330.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q2,2013-04-01,2013-06-30,2013-08-09 16:52:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3611000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3611000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3611000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12460000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19269000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15658000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1135000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-31000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1151000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16809000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40586376.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:59:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8485000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8485000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8485000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4039000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12796000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-142500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-125665000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,134150000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15586000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16774000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,117376000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1706000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,115670000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,115670000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,115670000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39178289.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.93
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40320187.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.87
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.35
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4158000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4158000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4158000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8328000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15935000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24263000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20105000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1131000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1067000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21172000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41500000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41739272.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:37:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2931000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2931000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2931000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7095000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19261000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26356000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23425000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1142000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1083000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24508000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42300000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42300000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41921329.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:12:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3955000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3955000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,202000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,202000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3753000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7707000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19521000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6800000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34028000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30275000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1133000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,66000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1067000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31342000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42400000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42400000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42318906.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:08:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9642000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9642000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,595000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,595000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9047000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8262000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17776000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26038000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16991000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3522000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,131000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3391000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20382000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10258000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10124000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10124000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10124000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42243529.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42243529.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15264000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15264000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,754000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,754000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14510000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8145000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18161000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26306000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11796000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1357000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,192000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1165000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12961000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43432034.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:12:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21337000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21337000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,680000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,680000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20657000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13987000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18666000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32653000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11996000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1376000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13196000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44000000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43859504.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:12:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24550000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24550000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,591000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23959000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19490000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19416000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38906000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14947000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1396000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,146000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1250000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16197000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,20000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16177000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43700000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43700000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44042319.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q3,2015-07-01,2015-09-30,2015-11-06 16:08:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21204000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21204000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1996000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1996000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19208000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19231000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17614000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36845000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17637000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1390000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,133000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1257000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18894000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-20000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18914000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18914000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18914000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43946428.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43946428.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44100000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17535000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17535000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,929000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,929000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16606000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12169000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19358000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31527000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14921000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1430000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,204000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1226000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16147000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44900000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44900000.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44871503.0
Anacor Pharmaceuticals Inc ,ANAC,5493005R5TB1X0002W47,0001411158,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:12:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
